Nektar Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	98.43	90.12	92.06	101.91	152.92	Upgrade
Revenue Growth (YoY)	9.21%	-2.10%	-9.67%	-33.36%	33.41%	Upgrade
Cost of Revenue	30.69	33.77	21.64	24.9	19.48	Upgrade
Gross Profit	67.74	56.35	70.42	77.01	133.44	Upgrade
Selling, General & Admin	76.75	77.42	92.33	122.84	104.68	Upgrade
Research & Development	120.91	114.16	218.32	400.27	408.68	Upgrade
Operating Expenses	197.66	191.58	310.66	523.11	513.36	Upgrade
Operating Income	-129.92	-135.23	-240.24	-446.1	-379.92	Upgrade
Interest Expense	-28.11	-25.33	-28.91	-47.31	-37.12	Upgrade
Interest & Investment Income	14.5	19.01	6.78	2.73	18.28	Upgrade
Other Non Operating Income (Expenses)	-0.39	-1.15	33.31	-8.19	-	Upgrade
EBT Excluding Unusual Items	-143.92	-142.7	-229.05	-498.87	-398.76	Upgrade
Merger & Restructuring Charges	-15.67	-51.96	-135.93	-	-	Upgrade
Impairment of Goodwill	-	-76.5	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	40.39	-5.1	-	-	-	Upgrade
Other Unusual Items	-	-	-	-24.41	-45.19	Upgrade
Pretax Income	-119.2	-276.26	-364.98	-523.28	-443.95	Upgrade
Income Tax Expense	-0.24	-0.2	3.22	0.56	0.49	Upgrade
Net Income	-118.96	-276.06	-368.2	-523.84	-444.44	Upgrade
Net Income to Common	-118.96	-276.06	-368.2	-523.84	-444.44	Upgrade
Shares Outstanding (Basic)	206	190	187	183	179	Upgrade
Shares Outstanding (Diluted)	206	190	187	183	179	Upgrade
Shares Change (YoY)	8.24%	1.53%	2.10%	2.64%	2.05%	Upgrade
EPS (Basic)	-0.58	-1.45	-1.97	-2.86	-2.49	Upgrade
EPS (Diluted)	-0.58	-1.45	-1.97	-2.86	-2.49	Upgrade
Free Cash Flow	-177.18	-193.47	-309.68	-427.65	-320.55	Upgrade
Free Cash Flow Per Share	-0.86	-1.02	-1.66	-2.33	-1.79	Upgrade
Gross Margin	68.82%	62.53%	76.50%	75.57%	87.26%	Upgrade
Operating Margin	-131.99%	-150.05%	-260.97%	-437.76%	-248.45%	Upgrade
Profit Margin	-120.86%	-306.31%	-399.98%	-514.03%	-290.64%	Upgrade
Free Cash Flow Margin	-180.01%	-214.68%	-336.41%	-419.65%	-209.62%	Upgrade
EBITDA	-125.53	-127.41	-227.21	-431.96	-365.74	Upgrade
EBITDA Margin	-127.53%	-141.38%	-246.81%	-	-239.18%	Upgrade
D&A For EBITDA	4.39	7.82	13.03	14.15	14.18	Upgrade
EBIT	-129.92	-135.23	-240.24	-446.1	-379.92	Upgrade
EBIT Margin	-131.99%	-150.05%	-260.97%	-	-248.45%	Upgrade
Revenue as Reported	98.43	90.12	92.06	101.91	152.92	Upgrade

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q